Page 199 - Read Online
P. 199

Nikiforov et al. Vessel Plus 2017;1:192-5                                         Vessel Plus
           DOI: 10.20517/2574-1209.2017.21
                                                                                                  www.vpjournal.net
            Topic: Atherosclerosis and Related Diseases                                         Open Access

           Proinflammatory monocyte polarization

           in type 2 diabetes mellitus and coronary

           heart disease



           Nikita G. Nikiforov 1,2,3 , Karina O. Galstyan , Liudmila V. Nedosugova , Natalia V. Elizova , Kira I. Kolmychkova ,
                                                                                                         4
                                                                                      1
                                               4
                                                                      4
           Ekaterina A. Ivanova 5
           1 Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
           2 Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Ministry of Healthcare, 121552 Moscow, Russia.
           3 Institute for Atherosclerosis Research, Skolkovo Innovation Center, 121609 Moscow, Russia.
           4 Sechenov’s First Moscow State Medical University, 119992 Moscow, Russia.
           5 Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
           Correspondence to: Dr. Ekaterina A. Ivanova, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
           E-mail: kate.ivanov@gmail.com

           How to cite this article: Nikiforov NG, Galstyan KO, Nedosugova LV, Elizova NV, Kolmychkova KI, Ivanova EA. Proinflammatory monocyte
           polarization in type 2 diabetes mellitus and coronary heart disease. Vessel Plus 2017;1:192-5.

                                         ABSTRACT
            Article history:              Aim: Type 2 diabetes mellitus (T2DM) is associated with rapid progression of atherosclerosis.
            Received: 10 Jun 2017         There is no doubt that inflammation is involved in atherogenesis. Recent studies showed the
            Accepted: 20 Sep 2017         relationship between  the  development  of atherosclerotic plaque  formation and  the  amount
            Published: 28 Dec 2017        of pro-inflammatory (M1) activated macrophages in situ. Methods: The authors studied the
                                          ability of circulating monocytes isolated from patients with diabetes (n = 28), coronary heart
            Key words:                    disease (CHD) (n = 27) and healthy subjects (n = 50) to be activated into M1 phenotype in
            Type 2 diabetes mellitus,     vitro. Results: Increased levels of basal and stimulated secretion of tumor necrosis factor alpha
            coronary heart disease,       (TNF-α) was observed in diabetic patients compared with healthy subjects. On the contrary,
            M1/M2 monocyte polarization,
            oxidative stress,             in  patients  with  CHD,  decreased  secretion  of  the  pro-inflammatory  cytokine,  TNF-α,  was
            atherosclerosis,              found. A direct correlation between glycated hemoglobin (HbA1c) levels in T2DM patients
            inflammatory                  and basal secretion of TNF-α from monocytes was observed. Conclusion: The authors found
                                          diametrically different responses of monocytes from T2DM and CHD under pro-inflammatory
                                          stimuli.

           INTRODUCTION                                       Т2DM patients are more likely to exhibit an accelerated
                                                              development of atherosclerosis and have a 3-4-
                                                                                                            [2]
           Increased prevalence of type 2 diabetes mellitus   fold increased risk for cardiovascular mortality .
           (T2DM) around the globe has been deemed a “non-    Hyperglycemia is currently considered the main culprit
           infectious epidemic” and according to the International   for vascular lesion progression. A meta-analysis of 20
           Diabetes Federation, it is predicted that the number   different studies involving 95,783 patients, followed
           of patients with T2DM will reach 642 million people by   for 12 years, led to the conclusion that glucose is the
           2040 .                                             common underlying risk factor for atherosclerosis,
                [1]
                                                                                              Quick Response Code:
                       This is an open access article licensed under the terms of Creative Commons Attribution 4.0 International
                       License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
            and reproduction in any medium, as long as the original author is credited and the new creations are licensed under the
            identical terms.
            For reprints contact: service@oaepublish.com

            192       © The Author(s) 2017                                                                                                                                           www.oaepublish.com
   194   195   196   197   198   199   200   201   202   203   204